Virax Biolabs Group Ltd (VRAX) stock chart

VRAXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends March 31

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 6, 2026Score 9/30

$0.67+0.04 (+6.47%)

Close on Nov 12, 2026Market cap $386.74KP/E –Yield –

Daily, weekly, monthly, quarterly and yearly candles from end-of-day prices, adjusted for splits. Marks along the bottom: E for earnings, D for ex-dividend dates, S for stock splits. Drawings are saved in this browser for each symbol; indicators and chart settings carry across symbols.

See a number that looks wrong?